Brain atrophy at onset and physical disability in multiple sclerosis

Brain atrophy at onset and physical disability in multiple sclerosis

The aim of this study was to investigate if brain atrophy in multiple sclerosis (MS) patients during the disease onset predicts long term disability. METHODS: MS patients with follow-up time of at least 7 years from disease onset and with baseline and second magnetic resonance 12 months later were i...

Descripció completa

Dades bibliogràfiques
Autors principals:	Juan Ignacio Rojas, Liliana Patrucco, Cristina Besada, Laura Bengolea, Edgardo Cristiano
Format:	Article
Idioma:	English
Publicat:	Academia Brasileira de Neurologia (ABNEURO) 2012-10-01
Col·lecció:	Arquivos de Neuro-Psiquiatria
Matèries:	esclerosis múltiple atrofia cerebral Expanded Disability Status Scale
Accés en línia:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2012001000003&lng=en&tlng=en

Ítems similars

Natural History of Early Onset Multiple Sclerosis
per: J Gordon Millichap
Publicat: (2002-10-01)

Association between Expanded Disability Status Scale score and dietary antioxidant capacity in patients with multiple sclerosis
per: S. Mungan, et al.
Publicat: (2023-09-01)

Role of Visual Evoked Potentials in Multiple Sclerosis
per: Ammar A. Thame, et al.
Publicat: (2014-12-01)

The Role of Trace elements in Multiple Sclerosis.
per: Ammar A. Thamer, et al.
Publicat: (2014-07-01)

The Combined Effects of Training on Serum Levels of Interferon Gamma (INF-γ) and Expanded Scale Disability Status Scale of Patients with Multiple Sclerosis at Different Levels of Disability
per: Z Saberi, et al.
Publicat: (2017-02-01)

Assessment of the role of telemedicine in the outcome of multiple sclerosis patients
per: Mohamed Abd El-khalik Ahmed, et al.
Publicat: (2023-07-01)

Predictors of progression of multiple sclerosis in a sample of Egyptian patients
per: Manar A. Shawky, et al.
Publicat: (2024-01-01)

Predicting multiple sclerosis severity with multimodal deep neural networks
per: Kai Zhang, et al.
Publicat: (2023-11-01)

Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status
per: Renata Balnytė, et al.
Publicat: (2016-01-01)

Evaluation of the treatment efficacy of patients with multiple sclerosis using Barthel index and Expanded Disability Status Scale
per: Edina Tanovic, et al.
Publicat: (2014-09-01)

Apelin-13: A promising biomarker for multiple sclerosis?
per: Murat Alpua, et al.
Publicat: (2018-01-01)

Incapacidad laboral en esclerosis múltiple: a propósito de un caso Working disability in multiple sclerosis: a propos of a case
per: Gian C. Navarro Chumbes, et al.
Publicat: (2010-12-01)

Is it safe for Multiple Sclerosis patients to fast?
per: Soodeh Razeghi Jahromi
Publicat: (2015-12-01)

Multimodal evoked potential in monitoring activity relapsing and remitting multiple sclerosis
per: Poverennova I.E., et al.
Publicat: (2018-03-01)

A Study on the Direct and Indirect Costs of Multiple Sclerosis Based on Expanded Disability Status Scale Score in Khuzestan, Iran
per: Amin Torabipour, et al.
Publicat: (2014-01-01)

Quantification of the usage of symptomatic treatment in patients suffering from multiple sclerosis.
per: Erélido Hernández Valero, et al.
Publicat: (2007-08-01)

Quantification of the usage of symptomatic treatment in patients suffering from multiple sclerosis.
per: Erélido Hernández Valero, et al.
Publicat: (2007-08-01)

Tratamiento Quirúrgico de las Esclerosis Faciales.
per: Ricardo Salazar López
Publicat: (2006-06-01)

Red cell distribution width as a predictor of disability in relapsing-remitting multiple sclerosis
per: R. Rocha, et al.
Publicat: (2022-04-01)

Oligoclonal Band Status and Features of Radiological and Clinical Findings in Patients with Multiple Sclerosis in Lithuania
per: Emilija Aleksandravičiūtė, et al.
Publicat: (2023-05-01)

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
per: Gloria Donninelli, et al.
Publicat: (2021-03-01)

Natural course of multiple sclerosis in the first five years of the disease in the Kujawsko-Pomorskie district
per: Łukasz Rzepiński, et al.
Publicat: (2016-03-01)

Immunosenescence: the role of age in multiple sclerosis
per: A. Ostolaza Ibáñez, et al.
Publicat: (2023-05-01)

Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records
per: Erwan Muros-Le Rouzic, et al.
Publicat: (2023-12-01)

Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
per: Z.F. Anabel, et al.
Publicat: (2024-07-01)

Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity
per: Mohammed I. Oraby, et al.
Publicat: (2021-03-01)

Early detection of cognitive impairment in patients with multiple sclerosis
per: Poverennova I.E., et al.
Publicat: (2017-03-01)

Effectiveness of comprehensive neurorehabilitation treatment on the cognitive function of patients with relapsing-remitting multiple sclerosis
per: Làzaro Aurelio Vàzquez Gòmez, et al.
Publicat: (2022-05-01)

There is much to be learnt about the costs of multiple sclerosis in Latin America
per: Marina Romano, et al.
Publicat: (2013-08-01)

Utilizing Aerobic Capacity Data for EDSS Score Estimation in Multiple Sclerosis: A Machine Learning Approach
per: Seda Arslan Tuncer, et al.
Publicat: (2024-06-01)

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
per: María Inés Herrera, et al.
Publicat: (2019-10-01)

Impact of Affected Functional Systems on Primary Sexual Dysfunction in Women with Multiple Sclerosis
per: Parvin Rahnama, et al.
Publicat: (2017-03-01)

Correlations Between Disability Score, Optical Coherence Tomography and Microperimetry in Patients with Multiple Sclerosis
per: Guantay CD, et al.
Publicat: (2024-11-01)

Mindfulness-based stress reduction for people with multiple sclerosis – a feasibility randomised controlled trial
per: Robert Simpson, et al.
Publicat: (2017-05-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
per: Làzaro Aurelio Vàzquez Gòmez, et al.
Publicat: (2022-10-01)

Anxiety and depression in patients with multiple sclerosis
per: O.V. Somilo, et al.
Publicat: (2023-06-01)

Usefulness of diffusion tensor imaging in amyotrophic lateral sclerosis: potential biomarker and association with the cognitive profile
per: Marcelo Chaves, et al.

"Benign" multiple sclerosis: a variant of favorable disease course and the result of effective treatment
per: Makarov N.S., et al.
Publicat: (2018-03-01)

Presenting Symptoms and Disease Severity in Multiple Sclerosis Patients
per: Jason Ledesma, et al.
Publicat: (2021-01-01)

Vestibular-evoked myogenic potential: an easy neurophysiological tool for evaluating brain stem involvement in multiple sclerosis
per: Rabab Koura, et al.
Publicat: (2018-05-01)